Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides

Critical Reviews in Immunology

Volumn 17, Issue 5-6, 1997, Pages 481-495

  Atassi, M Zouhair ^a   Oshima, Minako ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acetylcholine receptor; Antibodies; Myasthenia gravis; Synthetic peptides; T cells

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; EPITOPE; RECEPTOR ANTIBODY; RECEPTOR SUBUNIT; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; PEPTIDES; RECEPTORS, CHOLINERGIC; T-LYMPHOCYTES;

EID: 0030667781     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. Brooke, M. H., A Clinician's View of Neuromuscular Disease, 2nd ed., Williams & Wilkins, Baltimore, 1986.
2. Walton, J., Disorders of Voluntary Muscle, 5th ed., Churchill Livingstone, Edinburgh, 1988.
3. Lewis, R. A., Selwa, J. F., and Lisak, R. P., Myasthenia gravis: immunological mechanisms and immunotherapy, Annal. Neurol., 37 (Suppl. 1), S51, 1995.
4. Changeux, J. P., Devillers-Thiery, A., and Chemouilli, P., Acetylcholine receptor: an allosteric protein, Science, 225, 1335, 1984.
5. McCormick, D. J. and Atassi, M. Z., Localization and synthesis of the acetylcholine-binding site in the α-chain of the Torpedo californica acetylcholine receptor, Biochem. J., 224, 995, 1984.
6. Drachman, D. B., McIntosh, K. R., Reim, J., and Baker, L., Strategies for treatment of myasthenia gravis, Ann. New York Acad. Sci., 681, 515, 1993.
7. Shah, A. and Lisak, R. P., Immunopharmacologic therapy in myasthenia gravis, Clin. Neuropharmacol., 16, 97, 1993.
8. Drug Information Branch (HFD-210), FDA Investigational New Drug Application Packet, 1997.
9. Noda, M., Takahashi, H., Tanabe, T., Toyosato, M., Furutani, Y., Hirose, T., Asai, M., Inayama, S., Miyata, T., and Numa, S., Primary structure of α-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence, Nature (London), 299, 793, 1982.
10. Noda, M., Takahashi, H., Tanabe, T., Toyosato, M., Kilyotani, S., Hirose, T., Asai, M., Takashima, H., Inayama, S., Miyata, T., and Numa, S., Primary structures of β- and δ-subunit precursors of Torpedo californica acetylcholine receptor deduced from cDNA sequences, Nature (London), 301, 251, 1983.
11. Claudio, T., Ballivet, M., Patrick, J., and Heinemann, S., Nucleotide and deduced amino acid sequences of Torpedo californica acetylcholine receptor γ subunit, Proc. Natl. Acad. Sci. U.S.A., 80, 1111, 1983.
12. Isenberg, K. E., Mudd, J., Shah, V., and Merlie, J. P., Nucleotide sequence of the mouse muscle nicotinic acetylcholine receptor α subunit, Nucleic Acids Res., 14, 5111, 1986.
13. Buonanno, A., Mudd, J., Shah, V., and Merlie, J. P., A universal oligonucleotide probe for acetylcholine receptor genes: selection and sequencing of cDNA clones of the mouse muscle β subunit, J. Biol. Chem., 261, 16451, 1986.
14. Yu, L., LaPolla, R. J., and Davidson, N., Mouse nicotinic acetylcholine receptor γ subunit cDNA sequence and gene expression, Nucleic Acids Res., 14, 3539, 1986.
15. LaPolla, R. J., Mayne, K. M., and Davidson, N., Isolation and characterization of a cDNA clone for the complete protein coding region of the δ subunit of the mouse acetylcholine receptor, Proc. Natl. Acad. Sci. U.S.A., 81, 7970, 1984.
16. Noda, M., Furutani, Y., Takahashi, H., Toyosato, M., Tanabe, T., Shimizu, S., Kikyotani, S., Kayano, T., Hirose, T., Inayama, S., and Numa, S., Cloning and sequence analysis of calf cDNA and human genomic DNA encoding α-subunit precursor of muscle acetylcholine receptor, Nature (London), 305, 818, 1983.
17. Beeson, D., Brydson, M., and Newsom-Davis, J., Nucleotide sequence of human muscle acetylcholine receptor β-subunit, Nucleic Acids Res., 17, 4391, 1989.
18. Beeson, D., Brydson, M., Betty, M., Jeremiah, S., Povey, S., Vincent, A., and Newsom-Davis, J., Primary structure of the human muscle acetylcholine receptor cDNA cloning of the γ and ε subunits, Eur. J. Biochem., 215, 229, 1993.
19. Luther, M. A., Schoepfer, R., Whiting, P., Casey, B., Blatt, Y., Montal, M. S., Montal, M., and Lindstrom, J., A muscle acetylcholine receptor is expressed in the human cerebellar inedulloblastoma cell line TE671, J. Neurosci., 9, 1082, 1989.
20. Takai, T., Noda, M., Furutani, Y., Takahashi, H., Notake, M., Shimizu, S., Kayano, T., Tanabe, T., Tanaka, K., Hirose, T., Inayama, S., and Numa, S., Primary structure of γ subunit precursor of calf-muscle acetylcholine receptor deduced from the cDNA sequence, Eur. J. Biochem., 143, 109, 1984.
21. Atassi, M. Z., Manshouri, T., and Yokoi, T., Recognition of inter-transmembrane regions of acetylcholine receptor α-subunit by antibodies, T cells and neurotoxins. Implications for membrane-subunit by antibodies, FEBS Lett., 228, 295, 1988.
22. Lee, C. Y., Recent advances and pharmacology of snake toxins, Adv. Cytopharmacol., 3, 1, 1979.
23. b gene and protects C57BL/ 10 mice from developing autoimmune myasthenia gravis, Clin. Immunol. Immunpathol., 62, 235, 1992.
24. Oshima, M., Ashizawa, T., Pollack, M. A., and Atassi, M. Z., Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit, Eur. J. Immunol., 20, 2563, 1990.
25. Ashizawa, T., Ruan, K. H., Jinnai, K., and Atassi, M. Z., Profile of the regions on the α-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis, Mol. Immunol., 29, 1507, 1992.
26. Yokoi, T., Mulac-Jericevic, B., Kurisaki, J., and Atassi, M. Z., T lymphocyte recognition of acetylcholine receptor: localization of the full T cell recognition profile on the extracellular part of the α chain of Torpedo californica acetylcholine receptor, Eur. J. Immunol., 17, 1697, 1987.
27. Mulac-Jericevic, B., Kurisaki, J., and Atassi, M. Z., Profile of the continuous antigenic regions on the extracellular part of the α-chain of an acetylcholine receptor, Proc. Natl. Acad. Sci. U.S.A., 84, 3633, 1987.
28. Oshima, M., Pachner, A. R., and Atassi, M. Z., Profile of the regions of acetylcholine receptor α chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor, Mol. Immunol., 31, 833, 1994.
29. Lennon, V. A., McCormick, D. J., Lambert, E. H., Griesmann, G. E., and Atassi, M. Z., Region of peptide 125-147 of acetylcholine receptor α-subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity and modulating autoantibodies, Proc. Natl. Acad. Sci. U.S.A., 82, 8805, 1985.
30. Shenoy, M., Oshima, M., Atassi, M. Z., and Christadoss, P., Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region α146-162 of acetylcholine receptor, Clin. Immunol. Immunopathol., 66, 230, 1993.
31. Rosenberg, J. S., Oshima, M., and Atassi, M. Z., B-cell activation in vitro by helper T cells specific to region α146-162 of Torpedo californica nicotinic acetylcholine receptor, J. Immunol., 157, 3192, 1996.
32. Christadoss, P., Immunogenetics of experimental autoimmune myasthenia gravis, Crit. Rev. Immunol., 9, 247, 1989.
33. Pachner, A. R., Kantor, F. S., Mulac-Jericevic, B., and Atassi, M. Z., An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides, Immunol. Lett., 20, 199, 1989.
34. Atassi, M. Z., Ruan, K., Jinnai, K., Oshima, M., and Ashizawa, T., Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide, Proc. Natl. Acad. Sci. U.S.A., 89, 5852, 1992.
35. bm12 gene is evidence for genetic exchange between mouse immune response genes, Nature (London), 308, 551, 1984.
36. bm12 mutation using site-directed mutagenesis and DNA-mediated gene transfer, J. Immunol., 139, 629, 1987.
37. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stem, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C., Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature (London), 364, 33, 1993.
38. b on binding with and antigen presentation of Torpedo acetylcholine receptor α-chain peptide 146-162, J. Immunol., 154, 5245, 1995.
39. Hohlfeld, R., Kalies, L, Kohleisen, B., Heininger, K., Conti-Tronconi, B. M., and Toyka, K. V., Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines, Neurology, 36, 618, 1986.
40. Krolick, K. A. and Urso, O. E., Analysis of helper-T-cell function by acetylcholine receptor reactive cell lines of defined AChR-subunit specificity, Cell. Immunol., 105, 75, 1987.
41. Atassi, M. Z., Molecular recognition of acetylcholine receptor. Recognition by α-neurotoxins and by immune and autoimmune responses and manipulation of the responses, Adv. Neuroimmunol., 4, 403, 1994.
42. Asthana, D., Fujii, Y., Huston, G. E., and Lindstrom, J., Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis is mediated by IL-4 and antigen-specific T cell factors, Clin. Immunol. Immunopathol., 67, 240, 1993.
43. Ofosu-Appiah, W., Mokhtarian, F., Shirazian, D., and Grob, D., Production of anti-acetylcholine receptor-α antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes, J. Lab. Clin. Med., 124, 231, 1994.
44. Shenoy, M., Goluszko, E., and Christadoss, P., The pathogenic role of acetylcholine receptor α-chain epitope within α146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice, Clin. Immunol. Immunopathol., 73, 338, 1994.
45. Young, C. R. and Atassi, M. Z., T lymphocyte recognition of sperm whale myoglobin: specificity of T cell recognition following neonatal tolerance with either myoglobin or synthetic peptides of an antigenic site, J. Immunogenet., 10, 161, 1983.
46. Mulac-Jericevic, B., Kurisaki, J., and Atassi, M. Z., Profile of the continuous antigenic regions on the extracellular part of the a chain of an acetylcholine receptor, Proc. Natl. Acad. Sci. U.S.A., 84, 3633, 1987.
47. Lee, W. Y. and Sehon, A. H., Abrogation of reaginic antibodies with modified allergens, Nature (London), 267, 618, 1977.
48. Savoca, K. V., Davis, F. F., and Palczuk, N. C., Induction of tolerance in mice by uncase and monomethoxypolyethylene glycol-modified uricase, Int. Arch. Allergy Appl. Immunol., 75, 58, 1984.
49. Atassi, M. Z. and Manshouri, T., Synthesis of tolerogenic monomethoxypolyethylene glycol and polyvinyl alcohol conjugates to peptides, J. Prot. Chem., 10, 623, 1991.
50. Adorini, L., Guery, J.-C., Rodriguez-Tarduchy, G., and Trembleau, S., Selective immunosuppression, Immunol. Today, 14, 285, 1993.
51. Steinman, L. and Mantegazza, R., Prospects for specific immunotherapy in myasthenia gravis, FASEB J., 4, 2726, 1990.
52. Hjelmstrom, P., Giscombe, R., Lefvert, A. K., Pirskanen, R., Kockum, I., Olsson, M. L., and Sanjeevi, C. B., HLA-DQ association in Swedish myasthenia gravis (MG) patients, Hum. Immunol., 44, 80, 1995.
53. Pile, K. D., Willcox, N., Bell, J. I., and Wordsworth, B. P., A novel HLA-DR4 allele (DRB1*0414) in a patient with myasthenia gravis, Tissue Antigens, 40, 264, 1992.
54. Horiki, T., Moriuchi, J., Inoko, H., Morita, K., Tsuji, K., Shinohara, Y., Ichikawa, Y., and Arimori, S., HLA-DPB1 allele associates with early-onset myasthenia gravis in Japan, Neurology, 43, 771, 1993.
55. Waldor, M. K., Sriram, S., McDevitt, H. O., and Steinman, L., In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor, Proc. Natl. Acad. Sci. U.S.A., 80, 2713, 1983.
56. Christadoss, P., Lindstrom, J., and Talal, N., Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies, Cellular Immunol., 81, 1, 1983.
57. Christadoss, P. and Dauphinee, M. J., Immunotherapy for myasthenia gravis: a murine model, J. Immunol., 136, 2437, 1986.
58. Shenoy, M., Baron, S., Wu, B., Goluszko, E., and Christadoss, P., IFN-α treatment suppresses the development of experimental autoimmune myasthenia gravis, J. Immunol., 154, 6203, 1995.
59. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature (London), 368, 215, 1994.
60. Bixler, G. S. and Atassi, M. Z., T-cell recognition of proteins: conclusions from the localization of the full T-cell recognition profiles of two native proteins, Biotechnology, 3, 47, 1985.
61. Rosenberg, J. S., Yun, Z., Wyde, P. R., and Atassi, M. Z., Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin, Vaccine, 13, 927, 1995.